Trials / Completed
CompletedNCT06763887
Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the immunogenicity and immune protection of COVID-19, especially the recently prevalent strains, against the background of current immunization in Chinese population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Interventions | No intervention |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2025-01-08
- Last updated
- 2025-01-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06763887. Inclusion in this directory is not an endorsement.